FORNELLI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 607
EU - Europa 304
AS - Asia 113
Totale 1.024
Nazione #
US - Stati Uniti d'America 604
IT - Italia 99
CN - Cina 64
IE - Irlanda 62
SE - Svezia 49
UA - Ucraina 27
SG - Singapore 20
GB - Regno Unito 13
DE - Germania 10
FR - Francia 10
VN - Vietnam 10
HK - Hong Kong 9
ES - Italia 8
PL - Polonia 8
BE - Belgio 5
CA - Canada 3
JP - Giappone 3
KR - Corea 3
NL - Olanda 2
RO - Romania 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
FI - Finlandia 1
HR - Croazia 1
IN - India 1
LV - Lettonia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 1.024
Città #
Chandler 131
Ashburn 70
Dublin 62
Fairfield 42
Torino 42
Beijing 32
Nyköping 30
Jacksonville 25
Woodbridge 22
Cambridge 18
Houston 18
Seattle 17
Wilmington 17
Singapore 14
Pisa 12
Ann Arbor 9
Fremont 8
San Mateo 8
Boston 7
Medford 7
Dearborn 6
Hong Kong 6
Nanjing 6
Warsaw 6
Princeton 5
Vigo 5
Xian 5
Dong Ket 4
Milan 4
Redwood City 4
Aosta 3
Brussels 3
Central District 3
Hefei 3
Norwalk 3
Santiago De Compostela 3
Toronto 3
Baotou 2
Edinburgh 2
Feltre 2
Genova 2
Hangzhou 2
Kunming 2
New York 2
Rochester 2
San Diego 2
Shanghai 2
Taipei 2
Turin 2
Villeurbanne 2
Akron 1
Albuquerque 1
Birmingham 1
Boardman 1
Bognor Regis 1
Brno 1
Bromsgrove 1
Changsha 1
Copenhagen 1
DeKalb 1
Greifswald 1
Guangzhou 1
Gunzenhausen 1
Göttingen 1
Hamburg 1
Helsinki 1
Ithaca 1
Kwangju 1
London 1
Los Angeles 1
Moncalieri 1
Mountain View 1
Nanchang 1
Napoli 1
Newcastle upon Tyne 1
Oslo 1
Peer 1
Phoenix 1
Porto 1
Riga 1
Rome 1
San Francisco 1
Santa Ana Heights 1
Seoul 1
Shaan 1
Sofia 1
Tokyo 1
Valenza 1
Wuhan 1
Zagreb 1
Zevenhuizen 1
Ürümqi 1
Totale 731
Nome #
Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function 140
Yeast-derived recombinant avenanthramides inhibit proliferation, migration and epithelial mesenchymal transition of colon cancer cells 124
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction 108
KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins 100
KRIT1 loss of function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 80
Multifunctional platinum@bsa-rapamycin nanocarriers for combinatorial therapy of cerebral cavernous malformation disease 73
KRIT1/CCM1 Loss-of-function Mutations Impair Anti-glycative and Anti-oxidant Systems Worsening High Fructose Diet-induced Hepatic Dismetabolism 73
Identification of risk factors and biomarkers of diagnostic and prognostic value associated with clinical progression and severity of cerebral cavernous malformations 70
KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance 63
KRIT1/CCM1 loss-of-function impairs advanced glycation endproducts receptors and detoxification and worsens fructose diet-induced hepatic dysmetabolism 62
Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease 61
KRIT1 loss-of-function induces a sustained Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 61
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress 18
NAD+ repletion with niacin counteracts cancer cachexia 12
Amino Acids in Cancer and Cachexia: An Integrated View 11
The BET inhibitor JQ1 targets fat metabolism and counteracts obesity 3
Totale 1.059
Categoria #
all - tutte 4.102
article - articoli 0
book - libri 0
conference - conferenze 2.084
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020171 0 2 2 17 7 8 31 26 34 18 12 14
2020/2021167 10 19 25 7 15 7 8 12 25 9 16 14
2021/2022193 10 2 9 2 20 5 17 18 2 8 55 45
2022/2023310 24 33 13 54 9 67 19 24 42 6 14 5
2023/2024149 19 34 1 4 5 12 2 42 2 6 6 16
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.059